Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.

Recs

4

3 Earnings Reports That Caught My Attention Last Week

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

After wrapping up an incredibly strong first quarter of earnings reports, we're nearing an end to the second quarter with many reports still coming in better than expected. With so many companies reporting during the weeks that comprise earnings season, it's easy for some earnings reports to fall through the cracks.

Each week this year, I've taken a look at three companies that could be worth further research after either beating or missing their profit expectations. Today, we'll take a gander at three more companies that reported earnings last week. If they slid under your radar, they deserve a look:

Company

Consensus EPS

Reported EPS

Surprise

Rite Aid (NYSE: RAD  ) ($0.04) ($0.03) 25%
Barnes & Noble (NYSE: BKS  ) ($0.93) ($0.98) (5%)
Micron Technology (Nasdaq: MU  ) ($0.20) ($0.32) (60%)

Source: Yahoo! Finance.

Rite Aid
Another quarter down, and the losses continue to stream in for Rite Aid. The first-quarter loss of $0.03, while a penny better than expectations, marked the 20th consecutive quarterly loss.

Rite Aid has actually seen its fair share of positives recently, which include rising same-store sales figures and a continuing squabble between Walgreen (NYSE: WAG  ) and Express Scripts that has led to both Rite Aid and CVS Caremark gaining pharmacy customers.

But aside from these rays of sunshine, there long-term forecast looks gloomier than Seattle in winter. Rite Aid retired $459 million in debt in February by issuing $481 million in debt due in 2020. With very little in the way of positive cash flow, Rite Aid is making very little progress on its nearly $6 billion in net debt. Rite Aid is also dealing with the negative effect a rise in generic pharmaceuticals has on margins in its pharmacy operations. The effect of those generics actually caused the company to forecast a full-year loss ranging from $0.13 to $0.29 for fiscal 2013.

Rite Aid may have topped Wall Street's expectations this quarter, but nothing has fundamentally changed with this train wreck.

Barnes & Noble
Speaking of train wrecks, enter Barnes & Noble, stage left.

Barnes & Noble was expected to slide in and vulture market share from Borders Group once in went bankrupt, and a Nook-excluded same-store sales rise of 7% demonstrates that that may be happening to a minimal extent, but not as much as I would have hoped to see. With content continuing to shift online, Barnes & Noble is doing its best to play catch-up to Amazon.com's Kindle and Apple's iPad, with limited success.

In its latest quarter, Barnes & Noble noted an 11% decline in Nook e-reader sales as it made the decision to pull its simply e-readers off retailers' shelves in favor of its Nook tablet, which offers a higher price point and better margins. Weakness was also attributed by management to low selling volumes and weak selling prices. Overall, however, Nook sales increased 34% over last year, and the Nook still holds around one-quarter of all digital reader market share, according to Wall Street analysts.

Perhaps the one bright spot for Barnes & Noble is Microsoft's (Nasdaq: MSFT  ) $300 million investment in expanding the Nook into the digital college textbook business -- perhaps the one area I feel Barnes & Noble may have an edge. Although partnering with Microsoft doesn't guarantee success (I'm looking right at you, Nokia), it's perhaps Barnes & Noble's last chance at remaining relevant.

Micron Technology
The commoditization of flash memory prices strikes again!

Micron, which supplies flash memory components for mobile phones and tablets, saw earnings fall well short of Wall Street's expectations as memory prices slipped despite better inventory management. The catch-22 with memory prices is that as prices slip, tech companies are encouraged to purchase more. This demand eventually reduces supply, but Micron's margins suffer in the meantime. When prices rebound, Micron's margins grow, but demand weakens from customers as prices rise. Sometimes, Micron just can't win for trying.

However, at just 71% of book value, Micron is beginning to look very attractive, especially when you consider that Microsoft's Windows 8 is due out later this year and should be a catalyst that increases memory sales. As long as you understand the fact that Micron's business is highly cyclical and dependent on global demand, it could be a company worth digging deeper into.

Foolish roundup
Sometimes an earnings beat or miss isn't as cut-and-dried as it appears. I've given my two cents on what's next for each of these companies -- now it's your turn to sound off. Share your thoughts in the comments section below, and consider adding these stocks to your free and personalized watchlist.

If you'd like the inside track on three more companies that could wind up in the earnings beat column, then I suggest you get a copy of our latest special report: "3 American Companies Set to Dominate the World." Did I mention the best part? This report is completely free, so don't miss out!

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...

Fool contributor Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.

The Motley Fool owns shares of Amazon.com, Microsoft, and Apple. Motley Fool newsletter services have recommended buying shares of Express Scripts, Amazon.com, Microsoft, and Apple, as well as creating a bull call spread position in Microsoft and Apple and writing puts on Barnes & Noble. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy that always exceeds expectations.


Read/Post Comments (2) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On June 25, 2012, at 6:29 PM, PharmDInvestor wrote:

    No mention of the Elpida deal? Is this not still a probability for MU? Any thoughts on the impact it would have or when it might be announced? Questions are all I've got for you today..

  • Report this Comment On June 26, 2012, at 2:08 AM, Jp1000000000 wrote:

    You say RAD is a long term bad investment but I think for $1.50 it's a great shot. What I wouldn't do with $100,000,000 to improve my business, selling common stock. It's a fortune 500 company is it not? GM went belly up for less than a buck and now it's like OH woman I should have bought that for a dollar!

Add your comment.

Compare Brokers

Fool Disclosure

DocumentId: 1923292, ~/Articles/ArticleHandler.aspx, 5/20/2013 1:58:45 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 15,342.72 -11.68 -0.08%
S&P 500 1,666.56 -0.91 -0.05%
NASD 3,494.01 -4.96 -0.14%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/20/2013 1:42 PM
RAD $2.96 Up +0.17 +6.07%
Rite Aid Corp CAPS Rating: **
MU $11.31 Down +0.00 +0.00%
Micron Technology,… CAPS Rating: ****
BKS $21.68 Up +1.68 +8.40%
Barnes & Noble, In… CAPS Rating: *
WAG $49.66 Up +0.05 +0.10%
Walgreen Company CAPS Rating: ****
MSFT $34.86 Down -0.01 -0.03%
Microsoft CAPS Rating: ***

Advertisement